|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory of Physiology, Faculty of Medicine, Free University of Brussels, Brussels, Belgium
2 Laboratory of Physiology, Faculty of Medicine, Free University of Brussels, Brussels, Belgium; Department of Anesthesiology and Critical Care, La Timone Hospital, Marseille, France
3 Department of Pathology, Erasme Hospital, Free University of Brussels, Brussels, Belgium
* To whom correspondence should be addressed. E-mail: benoit.rondelet{at}ulb.ac.be.
The renin-angiotensin-system is has been reported to be overexpressed in pulmonary arterial hypertension (PAH). We investigated the effects of angiotensin receptor-1 blockade by losartan on hemodynamics and signaling molecules in a piglet overflow model of early PAH. Twenty-six 3-weeks-old piglets were randomized to placebo or losartan therapy 1mg/kg/day after anastomosis of the inominate to the main pulmonary artery or after a sham operation. Three months later, the animals underwent a hemodynamic evaluation followed by pulmonary tissue sampling for morphometry, immunohistochemistry, and real-time-quantitative-PCR. Chronic systemic-to-pulmonary shunting increased the pulmonary vascular resistance from 2.5 ± 0.2 to 6.2 ± 0.3 mmHg.l-1.min.m-2 and arteriolar medial thickness from 13.6 to 25.4 %. These changes were associated with increased expressions of angiotensin-II and its type 1 (AT-1) and type 2 (AT-2) receptors, endothelin-1 and its receptor-B (ET-B), and angiopoietin-1, together with decreased expressions of bone morphogenic protein receptor-1A and -2 (BMPR-1A and BMPR-2) and unchanged expression of Tie-2. Pretreatment with losartan decreased shunt-induced pulmonary vascular resistance and medial thickness by respectively 51 % and 35%. Losartan therapy was associated with persistent overexpressions of angiotensin-II, AT-2, endothelin-1, ET-B, angiopoietin-1, and with a return to normal of the expression of BMPR-2. Conclusions: These results suggest that angiotensin-II contributes to in left-to-right shunt-induced PAH.
This article has been cited by other articles:
![]() |
V. G. DeMarco, J. Habibi, A. T. Whaley-Connell, R. I. Schneider, R. L. Heller, J. P. Bosanquet, M. R. Hayden, K. Delcour, S. A. Cooper, B. T. Andresen, et al. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2659 - H2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Faber, C. L. Szymeczek, S. S. Salvi, and H. Zhang Enhanced {alpha}1-adrenergic trophic activity in pulmonary artery of hypoxic pulmonary hypertensive rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2272 - H2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das Role of the Adventitia in Pulmonary Vascular Remodeling Physiology, April 1, 2006; 21(2): 134 - 145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |